The first certified BioPearl™ user in the Baltic countries

Dr. Andrius Pranculis became the first certified user of Terumo BioPearl™ resorbable drug-releasing microspheres in Lithuania!

BioPearl™ is an advanced microsphere technology used in transarterial chemoembolization (TACE). During this treatment, chemotherapy drugs are delivered directly into the artery supplying the tumor while simultaneously blocking blood flow—thus limiting the tumor’s oxygen and nutrient supply. A unique advantage of BioPearl™ microspheres is the ability to regain access to the therapeutic area, gradually restore blood flow, and apply intra-arterial treatment again.

This certificate marks an important step towards making innovative interventional oncology solutions more widely available in our region for liver tumor treatment. At the same time, it is a significant step forward in strengthening clinical cooperation and expanding interventional radiology practice within the medical community of the Baltic countries.

Share:

Related posts

First pulmonary cryoablation at Tartu University Hospital

The first pulmonary cryoablation procedure was successfully performed at Tartu University Hospital. This move strengthens the development of interventional oncology services in the region and provides more minimally invasive treatment options for patients with lung tumors.

Minimally Invasive Liver Cancer Treatment in Klaipeda

At Klaipėda University Hospital, a 70-year-old liver cancer patient who could not undergo surgery was given a minimally invasive treatment method – microwave ablation. During the procedure, the tumor is destroyed by precise exposure to heat, without damaging the surrounding tissues, and the patient’s recovery is faster and easier than after open surgery.